Show simple item record

FieldValueLanguage
dc.contributor.authorAnderson, Anna W
dc.contributor.authorMarinovich, M Luke
dc.contributor.authorHoussami, Nehmat
dc.contributor.authorLowry, Kathryn P
dc.contributor.authorElmore, Joann G
dc.contributor.authorBuist, Diana S M
dc.contributor.authorHofvind, Solveig
dc.contributor.authorLee, Christoph I
dc.date.accessioned2023-03-20T01:34:06Z
dc.date.available2023-03-20T01:34:06Z
dc.date.issued2022en_AU
dc.identifier.urihttps://hdl.handle.net/2123/30241
dc.description.abstractPurpose: The aim of this study was to describe the current state of science regarding independent external validation of artificial intelligence (AI) technologies for screening mammography. Methods: A systematic review was performed across five databases (Embase, PubMed, IEEE Explore, Engineer Village, and arXiv) through December 10, 2020. Studies that used screening examinations from real-world settings to externally validate AI algorithms for mammographic cancer detection were included. The main outcome was diagnostic accuracy, defined by area under the receiver operating characteristic curve (AUC). Performance was also compared between radiologists and either stand-alone AI or combined radiologist and AI interpretation. Study quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies 2 tool. Results: After data extraction, 13 studies met the inclusion criteria (148,361 total patients). Most studies (77% [n = 10]) evaluated commercially available AI algorithms. Studies included retrospective reader studies (46% [n = 6]), retrospective simulation studies (38% [n = 5]), or both (15% [n = 2]). Across 5 studies comparing stand-alone AI with radiologists, 60% (n = 3) demonstrated improved accuracy with AI (AUC improvement range, 0.02-0.13). All 5 studies comparing combined radiologist and AI interpretation with radiologists alone demonstrated improved accuracy with AI (AUC improvement range, 0.028-0.115). Most studies had risk for bias or applicability concerns for patient selection (69% [n = 9]) and the reference standard (69% [n = 9]). Only two studies obtained ground-truth cancer outcomes through regional cancer registry linkage. Conclusions: To date, external validation efforts for AI screening mammographic technologies suggest small potential diagnostic accuracy improvements but have been retrospective in nature and suffer from risk for bias and applicability concerns.en_AU
dc.language.isoenen_AU
dc.publisherElsevieren_AU
dc.relation.ispartofJournal of the American College of Radiologyen_AU
dc.rightsCreative Commons Attribution 4.0en_AU
dc.subjectartificial intelligenceen_AU
dc.subjectscreeningen_AU
dc.subjectmammographyen_AU
dc.titleIndependent External Validation of Artificial Intelligence Algorithms for Automated Interpretation of Screening Mammography: A Systematic Reviewen_AU
dc.typeArticleen_AU
dc.identifier.doi10.1016/j.jacr.2021.11.008
dc.type.pubtypePublisher's versionen_AU
dc.relation.arc1194410
dc.relation.otherNational Cancer Institute (R37 CA240403)
dc.relation.otherNational Cancer Institute (P01CA154292)
dc.relation.otherNational Breast Cancer Foundation Investigator Initiated Research Scheme grant (IIRS-20-011)
dc.relation.otherNational Breast Cancer Foundation (grant #EC-21-001)
dc.relation.otherAmerican Cancer Society Clinician Scientist Development Grant (CSDG-21-078-01-CPSH)
usyd.facultySeS faculties schools::Faculty of Medicine and Health::Sydney School of Public Healthen_AU
usyd.citation.volume19en_AU
usyd.citation.issue2en_AU
usyd.citation.spage259en_AU
usyd.citation.epage273en_AU
workflow.metadata.onlyYesen_AU


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.